Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marc Theoret"'
Publikováno v:
Journal of Clinical Oncology. 41:2706-2712
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28936a94a1ec4bcdc47cda9801de12f4
https://doi.org/10.1200/jco.23.00225
https://doi.org/10.1200/jco.23.00225
Autor:
Olga Marchenko, Rajeshwari Sridhara, Qi Jiang, Elizabeth Barksdale, Yuki Ando, Dinesh De Alwis, Katie Brown, Laura Fernandes, Mark T. J. van Bussel, Qiuyi Choo, Michael Coory, Elizabeth Garrett-Mayer, Thomas Gwise, Lorenzo Hess, Rong Liu, Sumithra Mandrekar, Daniele Ouellet, José Pinheiro, Martin Posch, Nam Atiqur Rahman, Khadija Rerhou Rantell, Andrew Raven, Sarem Sarem, Suman Sen, Mirat Shah, Yuan Li Shen, Richard Simon, Marc Theoret, Ying Yuan, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e45310ce9d3649ab6576517e025f0859
https://doi.org/10.1080/19466315.2023.2166099
https://doi.org/10.1080/19466315.2023.2166099
Autor:
Rajeshwari Sridhara, Olga Marchenko, Qi Jiang, Elizabeth Barksdale, Jie Chen, Nancy Dreyer, Lola Fashoyin-Aje, Elizabeth Garrett-Mayer, Nicole Gormley, Thomas Gwise, Lorenzo Hess, Sumithra Mandrekar, Francesco Pignatti, Khadija Rantell, Andrew Raven, Yuan-Li Shen, Harpreet Singh, Craig L. Tendler, Marc Theoret, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. 15:450-456
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba10746cc2f4bb67a79971f94cdb7e1c
https://doi.org/10.1080/19466315.2022.2128404
https://doi.org/10.1080/19466315.2022.2128404
Autor:
Rajeshwari Sridhara, Elizabeth Barksdale, Olga Marchenko, Qi Jiang, Yuki Ando, Erick Bloomquist, Michael Coory, Melissa Crouse, Evgeny Degtyarev, Theodor Framke, Boris Freidlin, David E. Gerber, Thomas Gwise, Filip Josephson, Lorenzo Hess, Paul Kluetz, Daniel Li, Sumithra Mandrekar, Martin Posch, Khadija Rantell, Bohdana Ratitch, Andrew Raven, Kit Roes, Kaspar Rufibach, Sinan B. Sarac, Richard Simon, Harpreet Singh, Marc Theoret, Andrew Thomson, Emmanuel Zuber, Yuan Li Shen, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. 15:444-449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::157c416fb3319593be3ff73b85c1142c
https://doi.org/10.1080/19466315.2022.2103181
https://doi.org/10.1080/19466315.2022.2103181
Autor:
Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, Cong Wang, Tianjiao Dai, Zhenzhen Xu, Xiaofei Wang, Marc Theoret, Tejashri Purohit-Sheth, Bindu George
Publikováno v:
Oncologist
In March 2021, the U.S. Food and Drug Administration granted accelerated approval to axicabtagene ciloleucel, a CD19-directed chimeric antigen receptor T-cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c679d101df2c4e8b231ab8728b3e3d
https://doi.org/10.1093/oncolo/oyac054
https://doi.org/10.1093/oncolo/oyac054
Autor:
Steven Lemery, Lola Fashoyin-Aje, Leigh Marcus, Sandra Casak, Julie Schneider, Marc Theoret, Paul Kluetz, Richard Pazdur, Julia A. Beaver
Publikováno v:
Annual Review of Cancer Biology. 6:147-165
In 2017 the FDA (US Food and Drug Administration) approved pembrolizumab, a programmed death 1 (PD-1) inhibitor, for the treatment of unresectable or metastatic, microsatellite instability–high (MSI-H) or mismatch repair–deficient (dMMR) solid tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b63bd985c5b6552e0d295b307c6a8dc
https://doi.org/10.1146/annurev-cancerbio-060921-021828
https://doi.org/10.1146/annurev-cancerbio-060921-021828
Autor:
Yuan-Li Shen, Xin Wang, Mushti Sirisha, Flora Mulkey, Jiaxi Zhou, Xin Gao, Lijun Zhang, Thomas Gwise, Shenghui Tang, Marc Theoret, Richard Pazdur, Rajeshwari Sridhara
Publikováno v:
Statistics in Biopharmaceutical Research. 15:300-309
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d0a4cc75e46495a649ba928e70531fa
https://doi.org/10.1080/19466315.2021.2008485
https://doi.org/10.1080/19466315.2021.2008485
Autor:
Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu, Tejashri Purohit-Sheth, Marc Theoret
Publikováno v:
Oncologist
In October 2021, the FDA approved brexucabtagene autoleucel (brexu-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy, for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9232ed36dce588d8590c73dc37bfa1e
https://europepmc.org/articles/PMC9526496/
https://europepmc.org/articles/PMC9526496/
Autor:
Margret Merino, Yvette Kasamon, Hongshan Li, Lian Ma, Ruby Leong, Jiaxi Zhou, Gregory Reaman, Wiley Chambers, Nicholas Richardson, Marc Theoret, Richard Pazdur, Nicole Gormley
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(8)
In January 2021, the U.S. Food and Drug Administration (FDA) approved crizotinib for pediatric patients 1 year and older and young adults with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). This is the first approval for pedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d67b4530b878a3439c985a676420e5
https://pubmed.ncbi.nlm.nih.gov/35561013
https://pubmed.ncbi.nlm.nih.gov/35561013
Autor:
Mark D. Stewart, Bruce McCall, Marcelo Pasquini, Allen S. Yang, Carolyn D. Britten, Meredith Chuk, R Angelo De Claro, Bindu George, Nicole Gormley, Mary M. Horowitz, Eric Kowack, Candice McCoy, Phuong Khanh Morrow, Emmanuel Okoye, Rosanna Ricafort, John Rossi, Elad Sharon, Marc Theoret, Ferdinando Vegni, Tai Yu, Jeff Allen
Publikováno v:
Cytotherapy. 24(7)
As cancer immunotherapies continue to expand across all areas of oncology, it is imperative to establish a standardized approach for defining and capturing clinically important toxicities, such as cytokine release syndrome (CRS). In this paper, we pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d7f3db31555dcdaaef6afcc55cb85d
https://pubmed.ncbi.nlm.nih.gov/35219582
https://pubmed.ncbi.nlm.nih.gov/35219582